Latest Breaking News On - High cardiovascular risk - Page 1 : comparemela.com

Ionis presents positive results from Phase 3 Balance study of olezarsen for familial chylomicronemia syndrome

Ionis presents positive results from Phase 3 Balance study of olezarsen for familial chylomicronemia syndrome
2news.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from 2news.com Daily Mail and Mail on Sunday newspapers.

United statesNoord hollandClin lipidolGouni bertholdij endocrErik stroesD wade walkeHayley sofferIonis pharmaceuticals incIonis pharmaceuticals investor contactAmsterdam university medical centersIonis pharmaceuticals media contactAmerican college of cardiologyPrnewswire ionis pharmaceuticals incIonis pharmaceuticalsNew england journalAnnual meeting

Experimental drug could further reduce triglycerides in the blood in high-risk patients, trial shows

Experimental drug could further reduce triglycerides in the blood in high-risk patients, trial shows
medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.

Briana bergmarkGeraldf wattsBrian bergmarkDivision of cardiovascular medicine at brighamAnnual scientific sessionNew england journalCardiovascular medicineHigh cardiovascular riskTreat hypertriglyceridemia

Ionis presents positive results from Phase 3 Balance study of olezarsen for familial chylomicronemia syndrome

– Olezarsen met the primary endpoint with statistically significant reduction of fasting triglycerides and showed substantial, clinically meaningful reduction.

Noord hollandUnited statesErik stroesGouni bertholdij endocrClin lipidolHayley sofferD wade walkeAmsterdam university medical centersIonis pharmaceuticals incAmerican college of cardiologyPrnewswire ionis pharmaceuticals incIonis pharmaceuticalsIonis pharmaceuticals investor contactIonis pharmaceuticals media contactNew england journalAnnual meeting

Positive olezarsen Phase 3 data in familial chylomicronemia syndrome to be presented at 2024 American College of Cardiology (ACC) annual meeting

Positive olezarsen Phase 3 data in familial chylomicronemia syndrome to be presented at 2024 American College of Cardiology (ACC) annual meeting
lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.

United statesGouni bertholdij endocrClin lipidolHealth promotionIonis pharmaceuticals incAmerican college of cardiologyIonis pharmaceuticalsAnnual meetingHigh cardiovascular riskPrimary resultsLate breaking clinical trialsConjugated antisenseFast trackOrphan drugBreakthrough therapy

American College of Cardiology ACC 24 Late-breaking Science and Guidelines Session Summary

American College of Cardiology ACC 24 Late-breaking Science and Guidelines Session Summary
dicardiology.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dicardiology.com Daily Mail and Mail on Sunday newspapers.

United statesAnniversary of american college cardiologySymposium of the heart rhythm societyClinical researchMedication management program to reduceAmerican heart associationAmerican college of cardiology sessionRisk factors among national football league alumniAmerican college of cardiologyGeorgia world congress centerHealth status in heart failure clinic trialOutcomes after technology assisted nonprescription rosuvastatin administrationAmerican collegeAnnual scientific sessionGeorgia world congressCardiovascular care